Published in JAMA on December 20, 1995
Racial composition of residential areas associates with access to pre-ESRD nephrology care. J Am Soc Nephrol (2010) 2.07
Socioeconomic differences in the uptake of home dialysis. Clin J Am Soc Nephrol (2014) 1.57
Pain in aging community-dwelling adults in the United States: non-Hispanic whites, non-Hispanic blacks, and Hispanics. J Pain (2006) 1.33
Racial disparities in renal replacement therapy. J Natl Med Assoc (2002) 1.15
The impact of race and ethnicity on receipt of family planning services in the United States. J Womens Health (Larchmt) (2009) 1.12
The role of diversity in the health care needs of California. West J Med (1998) 1.08
Is there "cherry picking" in the ESRD Program? Perceptions from a Dialysis Provider Survey. Clin J Am Soc Nephrol (2009) 0.93
The Legacy of the U. S. Public Health Services Study of Untreated Syphilis in African American Men at Tuskegee on the Affordable Care Act and Health Care Reform Fifteen Years After President Clinton's Apology. Ethics Behav (2012) 0.87
Characteristics and performance of minority-serving dialysis facilities. Health Serv Res (2013) 0.82
Dialysis modality selection among patients attending freestanding dialysis facilities. Health Care Financ Rev (1997) 0.77
Social Determinants of Racial Disparities in CKD. J Am Soc Nephrol (2016) 0.76
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis (2001) 3.75
Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol (1996) 2.17
Demographic and geographic variability of kidney stones in the United States. Kidney Int (1994) 1.75
Mortality in end-stage renal disease is associated with facility-to-facility differences in adequacy of hemodialysis. J Am Soc Nephrol (1998) 1.68
F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity. Haemophilia (2011) 1.66
Incidence of inhibitors in a cohort of 838 males with hemophilia A previously treated with factor VIII concentrates. J Thromb Haemost (2006) 1.65
Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis (1999) 1.59
Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry. Am J Transplant (2012) 1.52
Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US). Haemophilia (2011) 1.47
Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol (1997) 1.43
Race and sex differences in the identification of candidates for renal transplantation. Am J Kidney Dis (1992) 1.39
Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities. Am J Transplant (2014) 1.27
Health care expenditures for Medicaid-covered males with haemophilia in the United States, 2008. Haemophilia (2011) 1.21
Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008. Haemophilia (2011) 1.17
Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance. J Thromb Haemost (2012) 1.09
Complications with permanent peritoneal dialysis catheters: experience with 154 percutaneously placed catheters. Nephron (1988) 1.08
Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension (1997) 1.06
Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study. J Thromb Haemost (2013) 1.05
Peritoneal dialysis adequacy and risk of death. Kidney Int (2000) 1.04
Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage. Am J Hematol (2001) 1.04
Evidence of porcine endogenous retroviruses in porcine factor VIII and evaluation of transmission to recipients with hemophilia. J Infect Dis (2001) 1.01
Race and the risk of peritonitis: an analysis of factors associated with the initial episode. Kidney Int (1994) 1.00
Facility mortality rates for new end-stage renal disease patients: implications for quality improvement. Am J Kidney Dis (1994) 0.93
In non-severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case-control study. J Thromb Haemost (2010) 0.91
Baseline characteristics in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol (1993) 0.90
Dialysis survival in a large inner-city facility: a comparison to national rates. J Am Soc Nephrol (1995) 0.86
Bleeding disorders in neonates. Haemophilia (2010) 0.85
Risk factors for hospital utilization in chronic dialysis patients. Southeastern Kidney Council (Network 6). J Am Soc Nephrol (1996) 0.84
The physician and patient education: a review. Patient Educ Couns (1986) 0.82
Racial variation in autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 0.81
Family history of end-stage renal disease does not predict dialytic survival. Am J Kidney Dis (2001) 0.81
Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres. Haemophilia (2011) 0.80
Improving the care of patients treated with hemodialysis: a report from the Health Care Financing Administration's ESRD Core Indicators Project. Am J Kidney Dis (1998) 0.80
Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database. Haemophilia (2013) 0.80
Low body weight is a risk factor for proteinuria in multiracial Southeast Asian pediatric population. Am J Kidney Dis (2001) 0.79
A prospective comparison of methods for determining if cardiovascular disease is a predictor of mortality in dialysis patients. Am J Kidney Dis (1994) 0.78
Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease. Haemophilia (2009) 0.78
From the facility to the network: DxBase moves on to SIMS and VISION to help track patient outcomes. Nephrol News Issues (1999) 0.77
Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol (1999) 0.77
Hepatitis B vaccination is effective by subcutaneous route in children with bleeding disorders: a universal data collection database analysis. Haemophilia (2014) 0.75
Association of overweight and obesity with the use of self and home-based infusion therapy among haemophilic men. Haemophilia (2013) 0.75
Similarity in joint function limitation in Type 3 von Willebrand's disease and moderate haemophilia A. Haemophilia (2013) 0.75
Applying the IOM perspective to the networks' approach to QA. Nephrol News Issues (1992) 0.75
Statewide community high blood pressure control programs. J Med Assoc Ga (1981) 0.75
American Medical Association report: "Health Policy Agenda for the American People". Patient Educ Couns (1988) 0.75
Practical steps towards improving patient compliance with anti-hypertensive therapy. J Med Assoc Ga (1981) 0.75
Initial antibiotic management of community acquired pneumonia. J Med Assoc Ga (1997) 0.75
Treatment center based quality improvement programs: a missing link in the chain of QA in the Medicare ESRD program. Nephrol News Issues (1991) 0.75
Erythropoietin and iron use in peritoneal dialysis patients. Report from the 1997 HCFA end-stage renal disease core indicators project. Am J Kidney Dis (1999) 0.75
The American Heart Association-Georgia Affiliate hypertension education network for physicians. J Med Assoc Ga (1985) 0.75
Retroperitoneal approach to abdominal aortic aneurysm. Positive outcomes for patient and nurse. AORN J (1991) 0.75
Linking the world with training and research for improving haemophilia care. Haemophilia (2008) 0.75
A dialysis outcomes computer database. Nephrol News Issues (1995) 0.75